Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Growth, Development Factors, Business Insights, Value Chain and Sales Channels Analysis 2027

The latest industry report on Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market provides comprehensive valuable insights on the market development activities demonstrated by industry players, growth opportunities and market sizing for Telehealth, complete with analysis by key segments, leading and emerging players, and geographies. The report is titled “Non-steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027”

The global non-steroidal anti-inflammatory drugs (NSAIDs) market size stood at USD 15.58 billion in 2019 and is projected to reach USD 24.35 billion by 2027, exhibiting a CAGR of 5.8% during the forecast period.

Recent Updates PDF Sample Copy of Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/102823

The report on Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market size analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favourable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

Drivers & Restraints

Chronic pain causes a major health and economic burden owing to the loss of productivity and treatment cost. Non-steroidal anti-inflammatory drugs are primarily used for the treatment of pain and inflammation. The rising prevalence of rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, migraine, and others is increasing the uptake of these drugs. With the increasing number of prescriptions, these have become the most commonly used drugs across the globe.

Increasing prevalence of pain and inflammation causing diseases is one of the leading factors driving the non-steroidal anti-inflammatory drugs market growth. Uptake of these drugs is rising gradually for the treatment of acute and chronic pain. Ibuprofen and diclofenac are the commonly prescribed drugs to provide relief form pain. According to the Centers for Disease Control and Prevention, in 2016, over 50 million adults in the U.S. had chronic pain and 19.6 million had high-impact chronic pain.

This report features an extensive study of the current market landscape and the likely future potential; associated with the Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market.

Key players covered in the global Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market research report:

  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • Bayer AG
  • AstraZeneca
  • Boehringer Ingelheim International GmbH
  • Zyla Life Sciences
  • Horizon Therapeutics plc
  • Others

Why choose our report?

  • Latest Technical Advancements
  • Comprehensive Report
  • Historical and Current Scenario
  • Potential Market Opportunities
  • Extensive Product Offering
  • Strong Industry Focus
  • Growth Dynamics
  • Value Chain Analysis
  • Robust Research Methodology

Speak To Analyst At: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/102823

Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Report covers the top key player’s data, including trades volume, price, revenue, gross profit, interview record, and business distribution, etc., these data help the buyer to know about the opponents better. This report also covers all the regions and top countries of the world, which shows a regional development position, including Industry size, volume, and value, as well as price data.

What Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Report Provides:

  • The report provides key statistics on the market status of the Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
  • The report provides a basic overview of the industry including its definition, applications, and manufacturing technology.
  • The report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for key vendors.
  • The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
  • The report estimates the market development trends of the Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market in 2022.

Regional Analysis

This report focuses on Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Size, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets.

Key Points from TOC:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
  • Global Statistics — Key Countries
  • New Product Launches
  • Pipeline Analysis
  • Regulatory Scenario — Key Countries
  • Recent Industry Developments — Partnerships, Mergers and Acquisitions
  • Global Non-steroidal Anti-Inflammatory Drugs [NSAIDs] Market Analysis, Insights and Forecast
  • Key Findings/ Summary
  • Market Analysis — By Product Type
  • Market Analysis — By Distribution Channel
  • Market Analysis — By Countries/Sub-regions
  • Competitive Analysis
  • Key Industry Developments
  • Global Market Share Analysis
  • Competition Dashboard
  • Comparative Analysis — Major Players
  • Company Profiles
  • Overview
  • Products and Services
  • SWOT Analysis
  • Recent developments
  • Major Investments
  • Regional Market Size and Demand
  • Strategic Recommendations

TOC Continued…………

Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/102823

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact:

Fortune Business Insights Pvt. Ltd.

Pune-411045,
Maharashtra, India.

Phone:

US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245

Email: [email protected]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts
Injectable Drug Delivery Market to Rise at a CAGR of 12.9% by 2027
Read More

Injectable Drug Delivery Market to Rise at a CAGR of 12.9% by 2027

Key Prominent Players Covered in the Injectable Drug Delivery Market Research Report Are Gerresheimer AG (Germany, Europe) , BD (New Jersey, U.S) , Insulet Corporation (Massachusetts, U.S) , Ypsomed AG (Switzerland, Europe) , SHL Medical AG (Switzerland, Europe) , Eli Lilly and Company (Indiana, U.S) , West Pharmaceutical Services, Inc. (Pennsylvania, U.S) , Elcam Medical (Israel, Middle East) , Pfizer Inc. (New York, U.S) , Others